ABSTRACT To clarify the immune mechanism in myocarditis, we examined by immunofluorescence techniques the serial changes in percentages of T and B lymphocytes in the heart, spleen, and peripheral blood of DBA/2 mice inoculated with encephalomyocarditis (EMC) virus (experiment I To confirm the involvement of T cells in the development of myocarditis, we also carried out studies in which BALB/c-nu/nu mice (group 1, n = 58), BALBI c-nu/+ mice (group 2, n = 54), and BALB/c-nu/nu mice injected with 5 x 107 spleen cells from BALB/c-nu/ + mice (group 3, n = 50) were inoculated with EMC virus (experiment II). Four mice from each of the three groups were killed on day 6 for virologic studies. In experiment II, there were no significant differences in the incidence of myocarditis among the three groups. Virus titrations of the heart and serum neutralizing antibody titers did not show any significant differences between the three groups on days 6 and 16. Fifty-two percent of group 2 mice (26 of 50) and 43% of those in group 3 (20 of 46) died on days 9 to 15, when congestive heart failure developed. However, only 9% of group 1 (five of 54) died during this period. Pathologic examination confirmed the presence of congestive heart failure in groups 2 and 3 but not in group 1 during this period. Cellular infiltrations and myocardial necrosis were minimal in group 1. Thus, the severity of myocarditis seems to be mediated by T cells. The so-called silent myocarditis seen clinically may be similar to myocarditis in BALB/c-nu/nu mice. Circulation 71, No. 6, 1247-1254, 1985 MYOCARDITIS can develop rapidly and progress to congestive heart failure.' Congestive heart failure has been reported to result from many viral injections in man.2 Thus, a relationship between viral infection and cardiomyopathy has been suggested,3'4 but complete evidence for it is still lacking. Recently we found congestive heart failure after inducing encephalomyocarditis (EMC) virus infections in BALB/c-nu/ + mice5 and have also observed severe myocarditis in DBA/2
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It may be that immune mechanisms play a role in the susceptibility to viral infection and in the severity of the disease. 3' 7 To test this hypothesis, we used an immunofluorescence method to examine the serial changes in percentages of T and B lymphocytes in the heart, spleen, and peripheral blood of DBA/2 mice inoculated with EMC virus (experiment I), and also carried out studies in which BALB/c-nu/nu mice (socalled nude), BALB Experiment II. The test groups consisted of 58 BALB/c-nu/nu mice (group 1), 54 BALB/c-nu/+ mice (group 2), and 50 BALB/c-nu/nu mice injected 2 weeks before the virus inoculation with 5 x 107 spleen cells of BALB/c-nu/ + mice (group 3).
At 6 weeks of age, mice in these three groups were inoculated intraperitoneally with 0.1 ml of virus suspension containing 102 5 TCD50 per 0. 1 ml. These mice were observed daily for 15 days after the virus inoculation. The surviving mice were killed on day 16 . After gross inspection of the heart for alterations in myocardial appearance, the hearts were processed for histologic or virologic studies.
Four mice from each of the three groups were killed on day 6 HEART 2W::: FIGURE 1. Lymphocytes (left) and fluorescence-positive cells (right) in the heart on day 14 (experiment I). On day 14, positive cells in the heart were almost all T cells.
for virologic study, and their hearts were processed for histologic study.
Pathologic study. The hearts were fixed in a 10% formalin solution, sectioned transversely at the midportion of the ventricle, embedded in paraffin, and stained with hematoxylin-eosin. The DEach datum obtained from five to 10 hearts (for adequate numbers of lymphocytes).
The percentage of T cells was greatly decreased in the peripheral blood (figure 2, A) and moderately decreased in the spleen (figure 2, B) on days 10 to 15, and returned to the control levels on days 60 to 90. On day 90, T cells were 54.10% of those in the peripheral blood and 38.30% of those in the spleen. B cells in the peripheral blood and spleen did not change significantly throughout the entire period. In the myocardium, however, approximately 80% of the cells were T cells and only about 7% were B cells on days 7 and 14 ( figure 2, C) Mortality. As reported previously,5 the mortality rate in group 2 was highest on day 4 and then decreased gradually, but increased again between days 10 and 15 ( figure 3, B) . Mice that died on days 9 to 15 showed pleural effusion, ascites, and congestion of the lungs and liver. The cause of death was congestive heart failure in each.
However, the mortality rate in group 1 was highest on the day 4 and decreased gradually until day 15 ( figure 3, A) . On days 9 to 15, only five mice died, and Vol. 71, No. 6, June 1985 these mice showed no signs of congestive heart failure. In other words, no BALB/c-nu/nu mice with myocarditis died of congestive heart failure during this period.
In group 3, the time course of death was similar to that in group 2 ( figure 3, C) , and the mice that died on days 9 to 15 in this group also showed pleural effusion, ascites, and congestion of the lungs and liver.
Fifty-two percent of group 2 (26 of 50) and 43% of group 3 (20 of 46) died on days 9 to 15, when congestive heart failure was evident. However, only 9% of group 1 (five of 54) died on days 9 to 15 (figure 4).
Incidence and severity ofmyocarditis. There were no significant differences in the incidence of myocarditis among the three groups ( Table 2 shows the pathologic grades in the three groups. Cellular infiltration, myocardial necrosis, and calcification were significantly less in group 1 than in groups 2 and 3 (p < .001; group 1 vs groups 2 and 3).
Pathologicfindings. The precise time course of cardiac lesions in group 2 has been reported elsewhere5 (figure SB). In brief, on day 4 or 5, necrotic foci appeared in the myocardium with small mononuclear cell infiltrations. After day 7, myocardial necrosis and inflammatory cell infiltrations became more extensive. Dilata- T lymphocytes. The course and severity of cardiac lesions in group 3 ( figure 5C ) were almost the same as in group 2, supporting the finding that presence of T lymphocytes is a key factor in the development of severe cardiac lesions.
Virus titration and neutralizing antibody titers. Virus titration of the heart and serum neutralizing antibody titers did not show any significant differences among the three groups on days 6 and 16 (table 3).
Discussion
In our previous studies, we found severe myocarditis in BALB/c-nu/ + mice inoculated with the M variant of EMC virus.5 Mice with severe myocarditis died of congestive heart failure in the acute stage of the illness. This animal preparation is considered to be an experimental model for congestive heart failure after EMC virus myocarditis. In addition, we also found severe myocarditis caused by EMC virus in an inbred strain of DBA/2 mice. Pathologic study revealed striking histologic similarities between DBA/2 mice with myocarditis in the chronic stage and some patients with this virus, the macrophage barrier, the ability to produce antiviral antibody, and cell-mediated immunity.
Genetic factors may play a role in the susceptibility to infection and the severity of the disease. Thus, to determine the role of immunomechanisms -particularly the significance of T lymphocytes in the severity and course of the disease, we studied experimental myocarditis with use of these two animal preparations.
In experiment I, T cells decreased markedly in the peripheral blood and accounted for approximately 80% of the cells in the myocardium in the acute stage of myocarditis. The percentage of B cells did not change significantly throughout the entire period. Thus, it may be mainly T cells that are involved in the development of myocarditis in this animal preparation. This is the first serial demonstration of lymphocyte populations in experimental viral myocarditis in mice.
In experiment II, we found severe myocarditis in both BALB/c-nu/ + mice and BALB/c-nu/nu mice injected with spleen cells from BALB/c-nu/ + mice, and x 12; those of b (left ventricular wall) and c (right ventricular free limited or mild myocarditis in BALB/c-nu/nu mice. In addition, we found a high death rate due to congestive heart failure on days 9 to 15 in BALB/c-nu/ + mice and BALB/c-nu/nu mice injected with spleen cells from BALB/c-nu/+ mice, but not in BALB/c-nu/nu Recently, T cell-mediated immunity had been reported in the pathogenesis of coxsackievirus B myocarditis in mice.4''3''4 The severity of myocarditis is reduced in animals depleted of T cells, and studies in vitro have shown that infection stimulates the production of cytotoxic T cells.4' 13 Huber and his colleagues1' 14 reported that cytotoxic T lymphocytes were involved in the pathogenesis of the myocyte damage that occurs in coxsackievirus myocarditis in mice. To understand the significance of cytotoxic T cells in vivo, however, we must consider which other cells are involved in their activation.
Reduced suppressor activity has been reported in patients with dilated cardiomyopathy and myocarditis. 15 16 Although further studies are needed, this animal preparation of BALB/c-nu/nu (athymic) mice with EMC virus infection may represent a condition comparable to that of patients with so-called silent myocarditis. In other words, the spectrum from silent to severe myocarditis depends on the immune status of individual patients, even when they have the same susceptibility to viral infection. It may be that the incidence of silent myocarditis is higher than expected.
In conclusion, it seems that the severity and development of myocarditis was mediated by T cells in our experimental preparations as well as in those used in previous experiments.4 ' 13 14 
